Skip to content

Greencare Capital - Further re: AGM

Announcement provided by

MaxRets Ventures Plc · MAX

18/06/2021 13:21

Greencare Capital - Further re: AGM
RNS Number : 4289C
Greencare Capital PLC
18 June 2021

18 June 2021


Greencare Capital plc

("Greencare" or "the Company")

Further re: AGM

Greencare Capital plc announces that, following the UK Government announcement that the COVID-19 restrictions which were expected to be lifted on 21 June 2021 have been extended to 19 July 2021, in order to protect the health and safety of the Company's Shareholders, Directors and Advisers, the Company's Annual General Meeting to be held on 29 June 2021 (the "AGM") will be held as a closed meeting and there will be no ability for shareholders to attend.


The quorum for the AGM will be arranged by the Company to ensure that the meeting is quorate.  Other Shareholders and their proxies should not attempt to attend the AGM in person as they will not be permitted to enter the venue.


Shareholders are therefore strongly encouraged to submit their votes by proxy in advance and to appoint "the Chair of the AGM" as their proxy. If a Shareholder appoints someone else as their proxy, that proxy will not be able to attend the meeting in order to cast the Shareholder's vote.


Shareholders wishing to raise any questions relating to the business of the AGM may do so by submitting them to the Chair of the AGM by email to in advance of the AGM. The Company will endeavour to publish and maintain an appropriate summary of responses on its website in advance of the AGM.




Greencare Capital plc

Nicholas Lee, Chairman

Richard Tonthat, CEO


+44 (0)20 7933 8780

Cairn Financial Advisers LLP

AQSE Corporate Adviser

Jo Turner / James Lewis


+44 (0)20 7213 0885




Walbrook PR Limited

Paul Vann/Nicholas Johnson


+44 (0)20 7933 8780

+44 (0)7768 807631


Greencare Capital plc is an investment company quoted on the Aquis Stock Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October 2019 and its shares were admitted to trading on 30 December 2019.


The Company's investment strategy is to focus on investments in cannabis sectors within countries predominantly in Europe whose jurisdictions have well-developed and reputable laws and regulations for its production, research and distribution; together with the CBD and hemp sectors.


The Company will invest directly or indirectly in public or private companies, in supply and distribution chains, or other business associated with the cannabis sector. Investments may take the form of debt or equity and it is expected that such investments will ordinarily seek capital growth in the medium term in preference to income.


The Company will not invest in the recreational cannabis sector, or in entities or activities supported by it, nor any other related activities which would be deemed illegal under UK legislation.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

View more ...

MAX announcementsAll announcements


  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal